Antibiotic utilization profile in surgical ward at secondary government hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20233891Keywords:
DU 90%, ATC/DDD, Prescribing indicators, Drug utilization, DURAbstract
Background: This study aimed to determine the profile of the antibiotic utilization in defined daily dose (DDD) units and DU 90% at surgical ward of secondary government hospital in Indonesia within six months period of study.
Methods: A retrospective cross-sectional study was conducted over six months on surgical ward patients prescribed with at least one oral or parenteral antibiotic during hospitalization. Data were collected from pharmacy dispensing data and evaluated using World Health Organization (WHO) DDD. Antibiotics DDD were analysed using DU 90% segmentation in order to know the 90 percent cumulative of antibiotic consumption in surgical ward. WHO prescribing indicators were used to examine the antibiotic prescribing pattern in DU 90% segment.
Results: Out of 319 antibiotic prescribed to surgical ward patients, 219 prescriptions were belonging to DU 90% segment including ceftriaxone (38.94%), moxifloxacin (16.41%), fosfomycin (14.06%), metronidazole (12.43%), and gentamicin (7.69%) in decreasing fashioned. Of the five groups of antibiotics belong to DU90%, ceftriaxone was the highest in DDD (272.5). The average number of antibiotic prescribed to patients were 1.64±0.92. The percentage of antibiotic prescribed by its generic name as well the prescribing of antibiotic from National list of essential medicines were 70.79% and 72.51%, respectively (optimal value 100%).
Conclusions: Our findings on using drug utilization 90% and prescribing indicators are practical for assessing the most widely used antibiotics in ward or hospital setting and to evaluate the quality of prescribing pattern. The antibiotic utilization profile in this study can be used to provide comparative data between hospital and beneficial for future policy making to improve prescribing practice.
Metrics
References
Zaha DC, Bungau S, Uivarosan D, Tit DM, Maghiar TA, Maghiar O, et al. Antibiotic consumption and microbiological epidemiology in surgery departments: Results from a single study center. Antibiotics. 2020;9(2):81.
Antimicrobial Resistance Collaborators. Articles Global burden of bacterial antimicrobial resistance in 2019 : a systematic analysis. Lancet. 2022;399(10325):629-55.
Nelson R. Antibiotic development pipeline runs dry. Lancet. 2003;362(9397):1726-7.
Limato R, Lazarus G, Dernison P, Mudia M, Alamanda M, Nelwan EJ, et al. Optimizing antibiotic use in Indonesia: A systematic review and evidence synthesis to inform opportunities for intervention. Lancet Reg Health Southeast Asia. 2022;2:100013.
Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ. 2010;340(7756):1120.
Oldenkamp R, Schultsz C, Mancini E, Cappuccio A. Filling the gaps in the global prevalence map of clinical antimicrobial resistance. Proc Natl Acad Sci U S A. 2021;118(1):e2013515118.
Zay Ya K, Win PTN, Bielicki J, Lambiris M, Fink G. Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(2):E2253806.
Malik B, Bhattacharyya S. Antibiotic drug-resistance as a complex system driven by socio-economic growth and antibiotic misuse. Sci Rep. 2019;9(1):1-12.
Ferdiana A, Liverani M, Khan M, Wulandari LPL, Mashuri YA, Batura N, et al. Community pharmacies, drug stores, and antibiotic dispensing in Indonesia: a qualitative study. BMC Public Health. 2021;21(1):1-10.
Llor C, Bjerrum L. Antimicrobial resistance: Risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229-41.
Chang Y, Cui Z, He X, Zhou X, Zhou H, Fan X, et al. Effect of unifaceted and multifaceted interventions on antibiotic prescription control for respiratory diseases: A systematic review of randomized controlled trials. Medicine (Baltimore). 2022;101(41):e30865.
Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. A Technical Guide to Implementing the World Health Organization’ s AWaRe Antibiotic Classification in MTaPS Program Countries. 2019;1-7. Available at: https://www. mtapsprogram.org/wp-content/uploads/2021/03/ USAID-MTaPS_Implementing-WHO-AWaRe-Classification.pdf. Accessed on 09 October 2023.
Nia SS, Hiremath SRR, Prasad S. Assessment of antimicrobial use pattern using world health organization prescribing indicators at a tertiary hospital: A prospective, observational study. J Appl Pharm Sci. 2018;8(6):132-8.
Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021;11(6):528.
Ibrahim M, Bazzi Z. A retrospective audit of antibiotic prescriptions in a Lebanese Hospital. Int J Infect Control. 2019;15(1).
World Health Organization. Introduction to Drug Utilization Research World Health Organization WHO International Working Group for Drug Statistics Methodology. 2003;8-74. Available at: https://www. who.int/publications-detail-redirect/828 0820396#:~: text=Overview,clinical%20pharmacologists%2C%20pharmacists%20and%20epidemiologists. Accessed on 09 October 2023.
Laporte J, Porta M, Capella D. Drug utilization studies: a tool for determining the effectiveness of drug use. Br J Clin Pharmacol. 1983;16(3):301-4.
Raut A, Cherian T, Chauhan S, Pawar A. Antibiotic utilization pattern at the surgery department of a tertiary care hospital. Asian J Pharm Clin Res. 2017;10(6):131-4.
Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, et al. Drug Utilization 90% of Urinary Tract Infections Drugs - A Simple Method for Assessing the Quality of Drug Prescribing. Res J Pharm Technol. 2011;4(8):1328-30.
Meena DK, Mathaiyan J, Thulasingam M, Ramasamy K. Assessment of medicine use based on WHO drug-use indicators in public health facilities of the South Indian Union Territory. Br J Clin Pharmacol. 2022;88(5):2315-26.
Kuster SP, Ruef C, Ledergerber B, Hintermann A, Deplazes C, Neuber L, et al. Quantitative antibiotic use in hospitals: Comparison of measurements, literature review, and recommendations for a standard of reporting. Infection. 2008;36(6):549-59.
Pratama NYI, Suprapti B, Ardhiansyah AO, Shinta DW. Analisis Penggunaan Antibiotik pada Pasien Rawat Inap Bedah dengan Menggunakan Defined Daily Dose dan Drug Utilization 90% di Rumah Sakit Universitas Airlangga. Indones J Clin Pharm. 2019;8(4):256.
Azyenela L, Tobat SR, Selvia L. Evaluasi Penggunaan Antibiotik di Instalasi Rawat Inap Bedah RSUD M. Natsir Kota Solok Tahun 2020. J Mandala Pharmacon Indones. 2022;8(1):1-10.
Sihite EN, Ramadhan AM, Samsul E. Evaluasi Penggunaan Antibiotik Secara Kuantitatif dan Kualitatif Pada Pasien Bedah Digestif di RSUD Abdul Wahab Sjahranie Samarinda. Proceeding Mulawarman Pharm Conf. 2021;14:214-21.
Saepudin S, Sendysagita C, Yuniarti E. Drug Utilization 90% Profile of Antibiotics Use during the Period of 2013 – 2017 at a Private Teaching Hospital in Yogyakarta. J Pharm Sci Community. 2022;19(1):8-14.
Ofori-Asenso R. A closer look at the World Health Organization’s prescribing indicators. J Pharmacol Pharmacother. 2016;7(1):51-4.
Kilipamwambu A, Bwire GM, Myemba DT, Njiro BJ, Majigo M V. WHO/INRUD core prescribing indicators and antibiotic utilization patterns among primary health care facilities in Ilala district, Tanzania. JAC-Antimicrobial Resist. 2021;3(2):1-7.
Menz BD, Charani E, Gordon DL, Leather AJM, Ramani Moonesinghe S, Phillips CJ. Surgical antibiotic prophylaxis in an era of antibiotic resistance: common resistant bacteria and wider considerations for practice. Infect Drug Resist. 2021;14:5235-52.
Nnadozie UU, Umeokonkwo CD, Maduba CC, Igwe-Okomiso D, Onah CK, Madubueze UC, et al. Antibiotic use among surgical inpatients at a tertiary health facility: a case for a standardized protocol for presumptive antimicrobial therapy in the developing world. Infect Prev Pract. 2020;2(4):100078.
Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017;96(1):1-15.
Ierano C, Manski-Nankervis JA, James R, Rajkhowa A, Peel T, Thursky K. Surgical antimicrobial prophylaxis. Aust Prescr. 2017;40(6):225-9.
Murray CJ, Ikuta KS, Sharara F. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.
Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011;86(2):156-67.
Sihite EN, Ramadhan AM, Samsul E. Evaluasi Penggunaan Antibiotik Secara Kuantitatif dan Kualitatif Pada Pasien Bedah Digestif di RSUD Abdul Wahab Sjahranie Samarinda. Proceeding Mulawarman Pharm Conf. 2021;14:214-21.
Sunil Kumar C. Prospective Study of Antibiotics Utilization in Multi-speciality hospitals in Narasaraopet at Guntur District, Andhra Pradesh. Res J Pharm Technol. 2021;14(4):1957.
Hidayah AN, Hasmono D, Thayyib M, Kuntaman K. The Pattern of Antibiotic Prescription and Antimicrobial Resistance of Gut Flora Escherichia coli at Aisyiyah Hospital, Bojonegoro. Folia Medica Indones. 2020;56(2):99.
Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16(1):1-9.
Mwita S, Mchau B, Minja W, Katabalo D, Hamasaki K, Marwa K. The magnitude of prescribing medicines by brand names in a tertiary hospital, Mwanza, Tanzania. J Med Access. 2022;6.
Kisamo O, Kilonzi M, Mikomangwa WP, et al. The magnitude of prescribing medicines by brand names at Muhimbili National Hospital, Tanzania. Med Access @ Point Care. 2020;4:239920261990014.
Downloads
Published
How to Cite
Issue
Section
